Dongfang Liu - Jul 15, 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Medical Officer
Signature
Dongfang Liu, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 05:21 PM
Next filing
Aug 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +490K $0.00 490K Jul 15, 2022 Common Stock 490K $3.61 Direct F1
transaction NUVB Stock Option (Right to Buy) Award $0 +293K $0.00 293K Jul 15, 2022 Common Stock 293K $3.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
F2 The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.